Institute for Global Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.
AIDS Behav. 2013 Jun;17(5):1796-808. doi: 10.1007/s10461-013-0432-1.
While it is widely agreed that HIV-related stigma may impede access to treatment and support, there is little evidence describing who is most likely to experience different forms of stigma and discrimination and how these affect disclosure and access to care. This study examined experiences of interpersonal discrimination, internalized stigma, and discrimination at health care facilities among HIV-positive adults aged 18 years and older utilizing health facilities in four countries in Sub-Saharan Africa (N = 536). Prevalence of interpersonal discrimination across all countries was 34.6 %, with women significantly more likely to experience interpersonal discrimination than men. Prevalences of internalized stigma varied across countries, ranging from 9.6 % (Malawi) to 45.0 % (Burkina Faso). Prevalence of health care discrimination was 10.4 % across all countries. In multiple regression analyses, we found positive, significant, and independent associations between disclosure and interpersonal discrimination and disclosure and support group utilization, and positive associations between both internalized stigma and health care discrimination and referral for medications.
虽然人们普遍认为与艾滋病相关的耻辱感可能会阻碍人们获得治疗和支持,但几乎没有证据描述哪些人最有可能经历不同形式的耻辱和歧视,以及这些耻辱和歧视如何影响他们的披露和获得护理。本研究调查了撒哈拉以南非洲四个国家(N=536)利用卫生设施的 18 岁及以上艾滋病毒阳性成年人在人际歧视、内化耻辱和医疗设施歧视方面的经历。在所有国家,人际歧视的发生率为 34.6%,女性比男性更有可能经历人际歧视。内化耻辱的发生率在各国之间有所不同,范围从 9.6%(马拉维)到 45.0%(布基纳法索)。所有国家的医疗保健歧视发生率为 10.4%。在多元回归分析中,我们发现披露与人际歧视以及披露与支持小组利用之间存在积极、显著和独立的关联,内化耻辱和医疗保健歧视与药物转介之间也存在积极关联。